Clinical trial
Non-alcoholic Steatohepatitis Registry Platform Study
NCT06123858 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-alcoholic Steatohepatitis Registry Platform Study
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 22, 2023
- Completion date
- October 17, 2025
- Enrollment
- 1,122 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
nash with fibrosis